Oral lichen ruber planus, including avohilmo

K11_ORAL_LICHEN_PLANUS_INCLAVO

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — K13.74 Hospital discharge: ICD-10 — K13.74 Cause of death: ICD-10 — K13.74 3 out of 7 registries used, show all original rules.	2144
4. Check minimum number of events None	2144
5. Include endpoints None	2144
6. Filter based on genotype QC (FinnGen only)	2144

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	K11_ORAL_LICHEN_PLANUS_INCLAVO
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	K1374
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K1374
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K1374
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Oral lichen ruber planus, including avohilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2144	1662	482
Unadjusted period prevalence (%)	0.49	0.57	0.21
Median age at first event (years)	64.22	64.28	64.01

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1837: Matched controls
18368

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K13.74

ICD-10 Finland

Lichen rubs planus in the mouth

+∞

323.0

1837

EKA10

NOMESCO Finland

Biopsy of cheek

71.7

323.0

644

137

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

28.4

323.0

533

260

SAA03

NOMESCO Finland

Extended examination of mouth

7.1

319.3

1332

4989

L43.8

ICD-10 Finland

Other lichen planus

37.5

312.7

404

137

L43.9

ICD-10 Finland

Lichen planus, unspecified

32.1

272.6

366

141

SBA00

NOMESCO Finland

Microbiological examinations

24.8

255.4

370

185

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

21.0

214.8

328

188

WZB00

NOMESCO Finland

Telephone receipt or other advice

4.6

193.1

961

3546

SAA01

NOMESCO Finland

Simple examination of mouth

6.1

175.4

1645

10755

SAA02

NOMESCO Finland

Basic examination of mouth

4.9

172.1

1544

9475

K13.78

ICD-10 Finland

Other change in the oral mucosa

17.7

166.8

270

177

ECA20

NOMESCO Finland

Biopsy of gingiva

41.6

162.2

204

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

19.5

151.4

236

138

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

3.7

145.9

980

4363

D07AC01

ATC

betamethasone; topical

3.6

140.6

975

4409

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

3.3

127.4

1025

5056

SXA10

NOMESCO Finland

Epithel biopsy of mouth

24.2

123.3

178

L43

ICD-10 Finland

Lichen planus

23.1

120.1

176

K13.29

ICD-10 Finland

Indefinite leukoplakia

24.2

115.1

166

WX110

NOMESCO Finland

Local anesthesy

3.6

111.7

1517

10432

D07AD01

ATC

clobetasol; topical

3.7

104.8

571

2013

SDA02

NOMESCO Finland

Parodonthologic therapy

3.0

99.7

869

4272

SFA10

NOMESCO Finland

Fillning on one surface of tooth

2.9

99.3

1229

7549

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

2.8

95.7

1110

6474

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

2.7

86.7

1281

8398

EB1AA

NOMESCO Finland

Tooth X-ray examination

2.7

85.6

1256

8167

K02.1

ICD-10 Finland

Caries of dentine

2.7

85.3

1243

8040

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

6.0

84.7

252

474

L43.0

ICD-10 Finland

Hypertrophic lichen planus

43.2

82.0

102

Z01.2

ICD-10 Finland

Dental examination

2.6

81.2

984

5659

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

2.5

79.3

1079

6582

KMAK

NOMESCO Finland

2.5

77.3

1146

7280

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.5

77.0

964

5582

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

2.8

75.2

642

2974

A07AA02

ATC

nystatin; oral

4.6

72.4

274

671

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

2.4

69.2

1081

6872

SDA01

NOMESCO Finland

Simple parodonthologic therapy

2.5

62.0

628

3133

L43.3

ICD-10 Finland

Subacute (active) lichen planus

66.1

60.8

K03.64

ICD-10 Finland

Dental calculus supragingival

2.4

59.0

665

3494

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

2.4

59.0

645

3337

D20

ICPC

Mouth/tongue/lip symptom/complaint

5.5

58.6

184

364

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

5.1

57.7

194

415

R01AD11

ATC

triamcinolone; nasal

3.4

56.6

316

1072

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

4.1

51.8

217

578

SAA04

NOMESCO Finland

Special inverstigation of mouth

4.4

48.8

190

471

B37.08

ICD-10 Finland

Other candidal stomatitis

19.7

48.7

-1

NOMESCO Finland

2.2

47.9

699

4052

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

2.3

47.7

584

3124

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

2.3

46.8

582

3129

D82

ICPC

Teeth/gum disease

2.1

45.4

739

4463

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

2.0

45.1

886

5776

WZA90

NOMESCO Finland

Other doctors statement

2.2

43.1

528

2800

K05.30

ICD-10 Finland

Periodontitis complex

2.7

43.0

336

1408

VALMI

NOMESCO Finland

2.2

42.5

537

2885

J02AC01

ATC

fluconazole; systemic

1.9

40.2

931

6358

L28.0

ICD-10 Finland

Lichen simplex chronicus

12.2

39.7

D19

ICPC

Teeth/gum symptom/complaint

2.1

39.6

579

3293

WX290

NOMESCO Finland

Other blockade of nerve

1.9

38.2

859

5765

B37.03

ICD-10 Finland

Chronic atrophic candida infection in the mouth

23.7

37.2

EJ2S1

NOMESCO Finland

Photography of oral mucosa

28.5

36.9

K13.20

ICD-10 Finland

Idiopathic leukoplakia

21.0

35.8

SFA00

NOMESCO Finland

Small filling

2.4

34.6

321

1464

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

2.5

34.0

305

1365

A01AC01

ATC

triamcinolone; local oral

5.9

31.5

158

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

10.5

30.5

XQ802

NOMESCO Finland

Epicutan test

3.9

30.4

131

355

EBA00

NOMESCO Finland

Extraction of tooth

1.9

30.0

630

4026

SBB10

NOMESCO Finland

Teeth copy

3.3

29.9

159

510

K13.28

ICD-10 Finland

Other leukoplakia or disorder of epithelium of the palate or tongue

17.4

29.3

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.6

29.2

226

927

R01AD09

ATC

mometasone; nasal

1.8

29.1

896

6465

K13.22

ICD-10 Finland

Erythroplakia of oral epithelium, including tongue

40.8

29.0

A01AB09

ATC

miconazole; local oral

2.6

28.9

233

978

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.9

28.6

523

3169

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

2.0

28.5

423

2367

N77.8*L43.9

ICD-10 Finland

Vulvovaginal ulceration and inflammation caused by lichen ruber planus

27.7

28.0

SXC05

NOMESCO Finland

Other oral or dental procedure

3.2

27.7

152

499

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.4

27.4

259

1182

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

4.6

27.1

216

TEA00

NOMESCO Finland

Biopsy of lip

9.3

26.8

E0000UV

ATC

1.7

26.5

761

5322

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

4.0

26.4

109

284

EMAK

NOMESCO Finland

3.8

26.3

116

321

K13.2

ICD-10 Finland

Leukoplakia and other disturbances of oral epithelium, including tongue

37.3

26.2

K05.31

ICD-10 Finland

Periodontitis pronounced

2.4

26.1

233

1031

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

2.5

25.3

211

899

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.5

25.3

220

960

K02.0

ICD-10 Finland

Caries limited to enamel

2.2

25.0

276

1354

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

18.4

24.8

A02BC05

ATC

esomeprazole; systemic

1.7

24.7

814

5889

D07AC13

ATC

mometasone; topical

1.8

24.2

579

3798

K05.18

ICD-10 Finland

Chronic gingivitis

3.2

23.9

130

424

EJB10

NOMESCO Finland

Excision of lesion of apex or body of tongue

13.1

23.4

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.7

23.1

166

648

D07AB02

ATC

hydrocortisone butyrate; topical

1.8

23.0

552

3615

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.0

22.9

361

2047

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.8

22.3

468

2930

L43.1

ICD-10 Finland

Bullous lichen planus

39.1

21.7

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.8

21.6

432

2658

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

3.7

21.2

262

K05.1

ICD-10 Finland

Chronic gingivitis

2.6

21.1

166

685

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.7

20.7

519

3425

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

2.2

20.5

226

1104

K12.10

ICD-10 Finland

Stomatitis NOS

10.2

20.4

K03.66

ICD-10 Finland

Tooth plaque

2.6

20.1

150

600

SXA20

NOMESCO Finland

Local application of medicine to mouth

2.8

20.1

135

508

A02BC02

ATC

pantoprazole; systemic

1.6

19.8

1204

9984

C03.1

ICD-10 Finland

Malignant neoplasm: Lower gum

106.2

19.6

M01AH05

ATC

etoricoxib; oral

1.6

19.6

1128

9210

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

19.2

212

1034

ULA02

NOMESCO Finland

Kolposcopy

2.2

19.1

207

1003

K12.18

ICD-10 Finland

Other forms of stomatitis

7.1

18.9

EJ2S1

SPAT

44.5

18.2

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

2.3

18.2

172

778

L01

ICPC

Neck symptom/complaint

1.9

18.0

279

1560

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

2.1

17.7

206

1025

EKC00

NOMESCO Finland

Suture of cheek

37.1

17.6

L44.3

ICD-10 Finland

Lichen ruber moniliformis

50.5

17.0

K12.00

ICD-10 Finland

Recurrent oral aphthae

5.6

17.0

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

17.0

364

2268

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

16.9

528

3664

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

16.0

805

6237

K13

ICD-10 Finland

Other diseases of lip and oral mucosa

14.6

15.8

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

15.8

393

2555

SXC03

NOMESCO Finland

Other oral or dental procedure

6.2

15.8

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.9

15.7

240

1332

M03BX02

ATC

tizanidine; oral

1.5

15.6

1164

9811

8070/3-C02.1

ICD-O-3

Squamous cell carcinoma, NOS, of border of tongue

19.4

15.6

WKPAL

NOMESCO Finland

4.1

15.5

149

SBA10

NOMESCO Finland

Measurement of excretion of saliva

5.8

15.4

EHA10

NOMESCO Finland

Biopsy of palate

7.6

15.2

R01AD12

ATC

fluticasone furoate; nasal

1.6

15.1

541

3863

M25.5

ICD-10 Finland

Pain in joint

1.6

14.9

540

3864

R06AE07

ATC

cetirizine; oral

1.5

14.9

814

6392

K04.1

ICD-10 Finland

Necrosis of pulp

2.0

14.5

197

1045

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.5

14.4

201

N89.5

ICD-10 Finland

Stricture and atresia of vagina

15.5

14.4

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

5.8

14.4

PAD

NOMESCO Finland

27.4

14.3

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

14.2

250

1458

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

14.1

468

3268

M79.6

ICD-10 Finland

Pain in limb

1.5

14.1

639

4799

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.6

14.0

106

428

D05BB02

ATC

acitretin; oral

3.5

13.9

186

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

2.1

13.9

153

746

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.9

13.9

224

1267

L08

ICPC

Shoulder symptom/complaint

1.7

13.8

359

2353

EDB00

NOMESCO Finland

Partial excision of mandible

20.2

13.8

A98

ICPC

Health maint/preventive medicine

2.6

13.7

1784

17049

A01AB04

ATC

amphotericin B; local oral

2.5

13.6

110

461

F45.8

ICD-10 Finland

Other somatoform disorders

2.3

13.6

134

620

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.0

13.5

180

949

U02

ICPC

Urinary frequency/urgency

1.8

13.5

264

1592

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.9

13.5

221

1257

R03AC02

ATC

salbutamol; inhalant

1.5

13.4

933

7636

SCA03

NOMESCO Finland

Preventive oral health care, extensive

2.6

13.4

389

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

2.0

13.3

178

939

R06AX27

ATC

desloratadine; oral

1.5

13.2

484

3458

R01AD08

ATC

fluticasone; nasal

1.5

13.1

532

3884

A02BC03

ATC

lansoprazole; oral

1.5

13.1

540

3959

H03AA01

ATC

levothyroxine sodium; systemic

1.5

13.1

471

3348

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

13.0

437

3053

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.9

13.0

197

1089

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

11.6

12.8

N02BE01

ATC

paracetamol; systemic, rectal

1.6

12.5

1554

14224

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.4

12.4

1014

8507

R01AD01

ATC

beclometasone; nasal

1.7

12.4

299

1916

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

12.2

209

1203

LEB00

NOMESCO Finland

Biopsy of vagina

3.4

12.2

174

G01AA10

ATC

clindamycin; vaginal

1.6

12.1

319

2094

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

11.9

193

1091

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

8.0

11.8

TUPEI

NOMESCO Finland

2.7

11.6

289

R13

ICD-10 Finland

Dysphagia

2.2

11.6

123

589

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

9.3

11.5

R09

ICPC

Sinus symptom/complaint

2.0

11.4

148

771

HMAK

NOMESCO Finland

1.8

11.4

219

1308

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.3

11.3

106

479

J01AA02

ATC

doxycycline; systemic

1.5

11.3

1422

12830

M79.1

ICD-10 Finland

Myalgia

1.7

11.2

232

1418

L03

ICPC

Low back symptom/complaint

1.5

11.2

429

3078

S18

ICPC

Laceration/cut

1.4

11.2

721

5746

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

11.1

223

1351

S29

ICPC

Skin symptom/complaint other

1.6

11.0

292

1912

XQ800

NOMESCO Finland

Prick test

2.0

10.9

138

713

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

10.8

393

2780

L17

ICPC

Foot/toe symptom/complaint

1.5

10.8

439

3187

J01DB01

ATC

cefalexin; oral

1.5

10.8

1440

13064

K03.00

ICD-10 Finland

Approximal wear

2.3

10.7

432

N77.8

ICD-10 Finland

Vulvovaginal ulceration and inflammation in other diseases classified elsewhere

28.2

10.7

SDA05

NOMESCO Finland

Very demanding and lengthy parodonthologic therapy

2.3

10.7

433

SGA01

NOMESCO Finland

Tooth opening as first aid

1.7

10.7

260

1664

K08.80

ICD-10 Finland

Toothache NOS

1.9

10.7

158

865

K05.12

ICD-10 Finland

Gingivitis (chronic) simple marginal

21.6

10.7

N03AX16

ATC

pregabalin; oral

1.5

10.7

432

3133

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.8

10.6

186

1078

R05

ICPC

Cough

1.5

10.5

387

2746

TLE00

NOMESCO Finland

Dilatation of vagina

110.6

10.4

SPA41

NOMESCO Finland

Precision impression for fixed dental prosthesis

4.3

10.4

H02AB06

ATC

prednisolone; systemic

1.4

10.4

804

6593

P06

ICPC

Sleep disturbance

1.8

10.3

170

966

EKB00

NOMESCO Finland

Excision of lesion of cheek

7.1

10.3

K14.61

ICD-10 Finland

Glossodynia

5.5

10.3

L43.2

ICD-10 Finland

Lichenoid drug reaction

18.9

10.3

P01AB01

ATC

metronidazole; oral, rectal

1.4

10.3

739

5982

T84.60

ICD-10 Finland

Gingivitis associated with dental implants

6.7

10.2

EAA10

NOMESCO Finland

Excision of lesion of lip

4.4

10.1

E000001

ATC

1.5

10.1

353

2473

EBA10

NOMESCO Finland

Surgical removal of tooth

1.8

10.1

170

975

A02BC04

ATC

rabeprazole; oral

1.8

10.1

170

976

J01FA10

ATC

azithromycin; systemic

1.4

10.1

1028

8818

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.8

10.1

173

998

K11.70

ICD-10 Finland

Hypoptyalism

6.1

10.0

R06AE09

ATC

levocetirizine; oral

1.6

10.0

256

1663

D07AB08

ATC

desonide; topical

1.8

9.9

184

1088

UJF32

NOMESCO Finland

Coloscopy

1.5

9.9

443

3271

SPA30

NOMESCO Finland

Grinding of a single crown and bridge pillar or a single post and crown

4.6

9.9

SPC10

NOMESCO Finland

Attachment of standard crone of tooth

3.5

9.9

132

ECA30

NOMESCO Finland

Excision of lesion of gingiva

5.1

9.9

C05AA08

ATC

fluocortolone; rectal, topical

1.6

9.8

266

1754

K07.60

ICD-10 Finland

Snapping jaw

2.2

9.8

459

M01AE02

ATC

naproxen; oral, rectal

1.4

9.7

995

8518

N06AA09

ATC

amitriptyline; systemic

1.7

9.7

202

1239

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.9

9.7

148

821

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

9.7

157

888

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

9.7

600

4714

N02AX02

ATC

tramadol; systemic, rectal

1.4

9.6

704

5696

B37.0

ICD-10 Finland

Candidal stomatitis

4.3

9.5

C03.0

ICD-10 Finland

Malignant neoplasm: Upper gum

100.5

9.4

8070/3-C06.0

ICD-O-3

Squamous cell carcinoma, NOS, of cheeck mucosa

100.5

9.4

EJB40

NOMESCO Finland

Hemiglossectomy

30.2

9.4

Z01.9

ICD-10 Finland

Special examination, unspecified

2.1

9.4

110

553

J01DA01

ATC

[U] cefalexin; systemic

1.4

9.3

1070

9302

K13.1

ICD-10 Finland

Cheek and lip biting

6.5

9.3

R52.9

ICD-10 Finland

Pain, unspecified

1.8

9.2

148

835

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

9.2

257

1702

DFF00

NOMESCO Finland

Pure tone audiometry

1.8

9.2

153

871

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

9.2

441

3298

K05.19

ICD-10 Finland

Gingivitis (chronic) ulcerative

3.1

9.2

162

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

9.2

1610

15079

SGA04

NOMESCO Finland

Very demanding opening and dilatation of root canal of tooth

1.8

9.2

172

1018

D83

ICPC

Mouth/tongue/lip disease

6.7

9.1

SDA12

NOMESCO Finland

Treatment of complicated periodontal disease

3.9

9.1

K03.80

ICD-10 Finland

Irradiated enamel

2.1

9.1

474

R06AX22

ATC

ebastine; oral

1.5

9.1

315

2202

K03.1

ICD-10 Finland

Abrasion of teeth

2.7

9.1

232

K07.23

ICD-10 Finland

Deep bite

3.5

9.1

115

L15

ICPC

Knee symptom/complaint

1.5

9.0

363

2616

E000006

ATC

1.9

9.0

139

773

B37.01

ICD-10 Finland

Acute athrophy candidal stomatitis

10.1

9.0

SGB30

NOMESCO Finland

Other demanding filling of root channel of tooth

1.7

9.0

184

1119

EBB10

NOMESCO Finland

Insertion of dental implant

3.5

9.0

116

C06.0

ICD-10 Finland

Malignant neoplasm: Cheek mucosa

18.7

8.9

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.0

8.9

116

606

K14.9

ICD-10 Finland

Disease of tongue, unspecified

12.6

8.9

G47.3

ICD-10 Finland

Sleep apnoea

1.5

8.8

327

2316

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.5

8.8

355

2561

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

8.7

286

1970

S02.51

ICD-10 Finland

Fracture of tooth, open

1.7

8.6

185

1144

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

2.2

8.6

410

J01CA04

ATC

amoxicillin; systemic

1.4

8.5

1397

12767

A07EA02

ATC

hydrocortisone; rectal

3.0

8.5

154

K13.7

ICD-10 Finland

Other and unspecified lesions of oral mucosa

9.0

8.5

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

8.5

278

1914

R74

ICPC

Upper respiratory infection acute

1.4

8.4

444

3371

S08

ICPC

Skin colour change

2.2

8.3

410

XQ848

NOMESCO Finland

Dermatological photography

2.8

8.3

180

K14.60

ICD-10 Finland

Glossopyrosis

6.2

8.3

D06BX01

ATC

metronidazole; topical

1.6

8.2

196

1246

R05

ICD-10 Finland

Cough

1.5

8.2

332

2390

H13

ICPC

Plugged feeling ear

1.5

8.2

282

1963

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.2

8.2

405

SPA02

NOMESCO Finland

Preparation for dental prosthetics

2.8

8.2

176

N03AX12

ATC

gabapentin; oral

1.5

8.1

272

1881

-60

ICPC

Result test/procedure

2.0

8.1

102

529

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.4

8.0

265

EB1MA

NOMESCO Finland

Cephalometry with X-ray

3.8

7.9

S21

ICPC

Skin texture symptom/complaint

1.6

7.9

208

1354

G44.2

ICD-10 Finland

Tension-type headache

1.6

7.9

236

1588

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

7.9

784

6597

LFA00

NOMESCO Finland

Incision of vulva or perineum

10.8

7.8

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

7.8

351

2583

SFC92

NOMESCO Finland

Other demanding adjuvant procedure of filling therapy

1.9

7.8

115

630

SPC01

NOMESCO Finland

Fixed dental crown

3.6

7.8

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

3.8

7.7

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.0

7.7

461

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.1

7.7

398

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.3

7.7

320

R07.0

ICD-10 Finland

Pain in throat

1.9

7.6

102

539

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

3.5

7.6

J05AB01

ATC

aciclovir; systemic

1.4

7.5

366

2730

N06AX11

ATC

mirtazapine; oral

1.4

7.5

532

4239

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

7.5

165

1030

SPAT1301

SPAT

No procedures

1.4

7.4

504

3987

EJW99

NOMESCO Finland

Other operation on tongue or floor of mouth

80.4

7.4

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

7.4

849

7266

SPAT1312

SPAT

General health counselling

1.4

7.4

509

4036

K05.11

ICD-10 Finland

Gingivitis (chronic) hyperplastic

7.7

7.4

B37.00

ICD-10 Finland

Acute pseudomembraneuous candidal stomatitis

7.7

7.4

SPAT1153

SPAT

Removal of sutures

1.4

7.4

537

4297

SPB06

NOMESCO Finland

Production of temporary clinic-made tooth- or implant-retained crown or bridge unit

6.0

7.4

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

7.3

494

3901

N76.3

ICD-10 Finland

Subacute and chronic vulvitis

4.7

7.3

SPAT1310

SPAT

Counselling related to known health issue

1.4

7.3

522

4159

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

7.3

399

3041

K13.21

ICD-10 Finland

Leukoplakia caused by tobacco

9.4

7.3

R21

ICPC

Throat symptom/complaint

1.5

7.2

285

2041

L04

ICPC

Chest symptom/complaint

1.9

7.2

502

SPAT1263

SPAT

Sampling

1.3

7.2

686

5714

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

7.1

207

1385

K12

ICD-10 Finland

Stomatitis and related lesions

12.1

7.1

J02AC02

ATC

itraconazole; systemic

1.4

7.0

322

2375

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

2.8

7.0

146

D01AE16

ATC

amorolfine; topical

1.6

7.0

195

1295

N06AB10

ATC

escitalopram; oral

1.4

7.0

308

2255

L66.1

ICD-10 Finland

Lichen planopilaris

13.8

6.9

107

Kela drug reimbursment

Pernicious anaemia

3.2

6.9

109

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.9

6.8

100

548

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

3.4

6.8

M01AB05

ATC

diclofenac; systemic, rectal

1.3

6.8

1168

10519

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

6.8

308

2268

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

6.8

188

1243

K30

ICD-10 Finland

Functional dyspepsia

1.6

6.7

185

1219

M54.6

ICD-10 Finland

Pain in thoracic spine

1.8

6.7

114

656

N06AX21

ATC

duloxetine; oral

1.6

6.7

185

1224

M01AX05

ATC

glucosamine; oral

1.4

6.7

351

2653

A07EA06

ATC

budesonide; oral, local oral

2.3

6.7

262

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

6.7

295

2158

D02AE01

ATC

carbamide; topical

1.8

6.6

115

667

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

6.6

475

3780

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

6.6

495

3967

K60.1

ICD-10 Finland

Chronic anal fissure

2.5

6.6

188

K13.6

ICD-10 Finland

Irritative hyperplasia of oral mucosa

4.0

6.6

S02

ICPC

Pruritus

2.3

6.6

246

N05CF02

ATC

zolpidem; oral

1.4

6.6

312

2316

L12

ICPC

Hand/finger symptom/complaint

1.5

6.5

231

1621

EAV

NOMESCO Finland

3.0

6.5

120

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

6.4

211

1454

K05.08

ICD-10 Finland

Another acute gingivitis

2.4

6.4

204

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

6.4

202

1378

R35

ICD-10 Finland

Polyuria

1.9

6.4

453

P01BA02

ATC

hydroxychloroquine; oral

1.6

6.3

158

1020

A02BA02

ATC

ranitidine; systemic

1.4

6.3

319

2394

M01AH01

ATC

celecoxib; oral (coxibs)

1.4

6.3

326

2455

B81

ICPC

Anaemia vit B12/folate deficiency

2.2

6.3

271

R07.3

ICD-10 Finland

Other chest pain

1.6

6.3

153

983

EJA10

SPAT

+∞

6.3

L13

ICPC

Hip symptom/complaint

1.4

6.2

278

2038

K02.2

ICD-10 Finland

Caries of cementum

2.0

6.2

369

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

6.2

184

1235

L12.8

ICD-10 Finland

Other pemphigoid

26.8

6.2

M79.7

ICD-10 Finland

Fibromyalgia

2.1

6.2

334

K29.4

ICD-10 Finland

Chronic atrophic gastritis

2.8

6.2

128

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

6.2

351

2684

WX110

SPAT

2.0

6.2

401

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

6.2

504

K13.03

ICD-10 Finland

Keilit UNS

7.7

6.1

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

4.7

6.1

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

6.1

566

4673

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

6.0

199

1369

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

6.0

598

4980

S02.53

ICD-10 Finland

Fracture of tooth root

2.3

6.0

230

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.5

6.0

173

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

6.0

678

5741

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3026389) Candida sp identified in Specimen by Organism specific culture

322

243

15.42

307.65

2.0

1.2

—

(40768804) Tissue Pathology biopsy report

1293

7994

2.56

95.18

2.5

2.1

—

(3000494) Fungus identified in Specimen by Culture

548

2236

2.95

94.17

1.9

1.5

—

(40768443) Skin Pathology biopsy report

225

833

2.90

44.06

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

197

773

2.71

34.34

1.3

1.2

u/ml

0.6

1.6

1.05

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1764

14957

2.01

33.18

5.1

4.3

pmol/l

14.8

0.41

1611

13634

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

118

5.38

31.14

1.4

1.3

titre

28.6

65.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

139

4.94

30.53

1.7

1.4

u/ml

22.5

22.6

0.00

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

636

4154

1.76

28.70

1.3

1.2

u/ml

2.1

1.5

0.37

180

1117

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1946

17420

2.27

27.09

6.3

5.1

mu/l

1.9

2.1

1.05

1794

15961

(3037522) Nuclear Ab [Titer] in Serum

440

2648

1.83

25.81

1.5

1.3

titre

620.2

549.2

0.29

105

572

(3013707) Erythrocyte sedimentation rate by Westergren method

1656

14119

1.76

25.79

4.9

4.2

mm/h

12.2

12.5

0.32

1544

13083

(3007164) IgA [Mass/volume] in Serum or Plasma

551

3589

1.72

24.46

1.4

g/l

2.4

0.03

337

2149

(40768797) Stomach Pathology biopsy report

449

2810

1.76

22.78

1.4

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

140

569

2.56

22.62

1.3

1.2

u/ml

10.1

31.3

—

(3048689) Calprotectin [Mass/mass] in Stool

370

2238

1.79

20.94

2.3

2.2

ug/g

140.3

126.3

0.24

290

1780

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

984

7617

1.54

20.62

2.1

1.9

pmol/l

100.1

97.3

0.98

449

3707

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1679

14670

1.67

20.44

7.5

7.8

u/l

75.2

78.5

2.92

1586

13816

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1916

17436

1.93

19.53

6.1

5.7

mmol/mol

39.1

39.7

2.35

1783

16139

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

109

427

2.64

18.98

1.3

1.2

u/ml

56.6

50.2

0.12

(3001122) Ferritin [Mass/volume] in Serum or Plasma

982

7735

1.50

18.14

3.0

2.8

ug/l

102.9

120.3

2.05

916

7163

(3006315) Basophils [#/volume] in Blood

1144

9308

1.49

17.92

6.2

5.9

e9/l

0.0

0.26

1007

8035

(3037467) Urinalysis macro (dipstick) panel - Urine

1480

12708

1.53

17.77

4.9

4.5

—

(3001604) Monocytes [#/volume] in Blood

1138

9271

1.48

17.57

6.2

5.9

e9/l

0.5

0.6

3.32

1006

7999

(3019198) Lymphocytes [#/volume] in Blood

1160

9496

1.48

17.41

6.2

6.0

e9/l

1.9

1.66

1034

8367

(3021960) Folate [Moles/volume] in Serum or Plasma

590

4200

1.56

17.38

1.5

nmol/l

21.9

21.4

0.33

507

3542

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

122

531

2.38

17.01

1.3

1.2

u/ml

2.8

10.0

1.74

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

120

523

2.37

16.69

1.3

1.2

u/ml

7.6

8.0

0.03

(3013115) Eosinophils [#/volume] in Blood

1170

9643

1.47

16.64

6.3

6.1

e9/l

0.2

0.04

1043

8456

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1979

18375

2.00

16.51

5.2

4.6

mmol/l

5.9

0.33

1808

16764

(3023103) Potassium [Moles/volume] in Serum or Plasma

2052

19371

2.38

15.48

15.6

15.9

mmol/l

4.0

0.07

2005

18875

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1999

18696

2.02

15.23

5.1

4.6

mmol/l

4.8

1.45

1848

17299

(3019550) Sodium [Moles/volume] in Serum or Plasma

2046

19316

2.30

14.99

15.5

15.7

mmol/l

139.7

0.02

2001

18851

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

410

2.46

14.93

1.3

1.2

u/ml

1.1

4.8

—

(36660697) Celiac disease serology panel - Serum

250

1483

1.78

14.84

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2024

19037

2.13

14.83

5.6

5.1

mmol/l

2.8

0.36

1856

17534

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1985

18561

1.94

14.52

5.0

4.5

mmol/l

1.5

0.04

1818

17075

(3024731) MCV [Entitic volume]

2127

20516

5.64

14.47

21.9

20.7

91.2

91.1

0.19

2106

20241

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1980

18504

1.92

14.43

14.1

14.0

mg/l

18.8

22.4

5.82

1553

14602

(3006504) Eosinophils/100 leukocytes in Blood

1057

8684

1.43

14.43

6.3

6.0

3.0

2.8

1.76

992

8070

(3026361) Erythrocytes [#/volume] in Blood

2127

20519

5.62

14.40

22.0

20.7

e12/l

4.5

1.56

2082

19961

(3010813) Leukocytes [#/volume] in Blood

2127

20520

5.61

14.38

22.0

20.8

e9/l

6.3

6.6

10.14

2080

19961

(3019069) Monocytes/100 leukocytes in Blood

1061

8727

1.43

14.37

6.7

6.3

8.7

8.5

0.95

1003

8152

(3018010) Neutrophils/100 leukocytes in Blood

1069

8808

1.43

14.32

6.2

5.9

55.8

56.8

2.45

1004

8218

(3000963) Hemoglobin [Mass/volume] in Blood

2127

20526

5.57

14.24

22.1

20.8

g/l

135.3

134.2

3.64

2105

20251

(3002030) Lymphocytes/100 leukocytes in Blood

1082

8943

1.42

14.19

6.4

6.1

29.4

28.4

2.68

1016

8307

(3035941) MCH [Entitic mass]

2126

20518

5.31

14.05

21.9

20.6

30.3

1.16

2105

20241

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1005

8209

1.42

14.03

2.4

2.3

nmol/l

80.2

79.2

0.55

916

7389

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

499

3566

1.52

13.98

1.4

1.3

iu/ml

34.1

35.7

0.09

166

1148

(3022096) Basophils/100 leukocytes in Blood

1029

8452

1.42

13.85

6.4

6.1

0.7

2.22

970

7862

(3007461) Platelets [#/volume] in Blood

2125

20512

5.06

13.81

22.0

20.7

e9/l

253.5

257.1

1.89

2087

20016

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

477

3385

1.53

13.79

1.4

1.3

u/ml

14.8

11.9

0.28

161

1336

(3031040) Bacteria [#/volume] in Urine by Automated count

1398

12163

1.43

13.35

4.9

4.5

e6/l

732.7

2479.3

1.15

163

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

763

5980

1.43

13.18

2.6

u/l

56.0

58.3

0.97

697

5511

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1920

17911

1.69

12.30

4.4

4.0

mmol/l

1.3

1.03

1752

16357

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2077

19888

2.42

12.02

12.0

10.9

u/l

25.5

25.6

0.02

2011

19218

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1283

11110

1.39

11.81

2.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

490

3607

1.46

11.58

1.5

1.4

—

(42870588) Differential panel, method unspecified - Blood

789

6355

1.38

11.14

6.3

5.8

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2067

19829

2.18

10.60

16.8

16.3

umol/l

72.1

73.3

1.38

2067

19824

(3024561) Albumin [Mass/volume] in Serum or Plasma

970

8124

1.35

10.52

4.3

4.8

g/l

36.4

35.6

5.23

902

7558

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1154

9933

1.35

10.41

5.2

6.4

umol/l

10.4

10.8

0.90

1091

9442

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

117

619

1.94

9.98

1.7

1.9

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1376

12209

1.35

9.92

3.3

3.1

u/l

42.2

48.4

2.49

1263

11327

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

568

4410

1.39

9.75

2.3

2.2

mg/l

2.7

3.0

1.46

481

3761

(3013826) Glucose [Moles/volume] in Serum or Plasma

1229

10736

1.34

9.75

4.2

4.6

mmol/l

6.6

6.7

0.49

1145

10069

(3035350) Ketones [Presence] in Urine by Test strip

1059

9065

1.33

9.59

3.8

estimate

0.0

0.00

212

1655

(40761511) CBC panel - Blood by Automated count

2017

19256

1.80

9.51

13.7

13.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

409

3009

1.44

9.50

1.5

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1895

17818

1.55

9.42

13.3

12.9

ml/min/173m2

81.0

80.2

1.23

1603

14721

(3015377) Calcium [Moles/volume] in Serum or Plasma

805

6644

1.34

9.26

2.9

3.5

mmol/l

2.4

0.25

694

5815

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1098

9477

1.33

9.25

5.7

6.7

mmol/l

1.2

1.18

923

8037

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

107

565

1.94

9.20

1.8

1.7

g/l

0.2

0.89

102

532

(3021601) Nitrite [Presence] in Urine by Test strip

1060

9122

1.32

9.03

5.0

5.1

estimate

0.0

0.50

213

1674

(3013650) Neutrophils [#/volume] in Blood by Automated count

1240

10915

1.32

8.96

9.0

9.4

e9/l

3.6

4.0

8.55

1104

9551

(3009261) Glucose [Presence] in Urine by Test strip

1066

9207

1.31

8.74

3.9

3.8

estimate

0.0

0.26

207

1641

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

108

588

1.88

8.49

1.7

1.6

g/l

1.2

0.52

103

555

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

206

1355

1.58

8.16

2.6

2.4

au/ml

39.2

25.8

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

260

1809

1.50

7.97

2.2

g/l

0.2

1.32

243

1705

(3028026) IgM [Mass/volume] in Serum or Plasma

176

1126

1.61

7.84

1.7

1.8

g/l

1.4

0.01

166

1022

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

630

5118

1.33

7.78

2.4

2.9

ng/l

628.4

1091.8

6.36

520

4347

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

146

2.70

7.59

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

146

2.70

7.59

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

146

2.70

7.59

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

211

1419

1.54

7.58

2.8

g/l

10.4

0.04

198

1288

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

740

6177

1.30

7.44

3.3

3.2

u/l

29.5

33.9

2.06

697

5869

(3024980) IgG subclass 4 [Mass/volume] in Serum

294

2.14

7.21

1.5

1.7

g/l

0.6

0.8

1.19

222

(3005322) IgE [Units/volume] in Serum or Plasma

185

1224

1.56

7.15

1.3

u/ml

112.4

178.7

1.73

174

1127

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

145

2.65

7.14

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

145

2.65

7.14

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

145

2.65

7.14

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

653

5391

1.30

7.05

1.8

1.7

mmol/l

1.3

1.4

2.92

569

4547

(3044889) 12 lead EKG panel

1471

13458

1.30

7.00

4.1

3.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

988

8610

1.27

6.94

5.0

6.0

mmol/l

1.2

1.50

887

7815

(3015736) pH of Urine

825

7037

1.28

6.88

3.6

3.5

—

5.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

275

1995

1.43

6.78

1.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

521

1.82

6.74

1.2

titre

115.0

81.7

—

(3022145) Colonoscopy Study observation

301

2222

1.41

6.73

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

198

1351

1.51

6.66

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.73

6.64

2.1

1.5

ug/l

8.5

8.9

0.22

(3007853) Bacteria identified in Skin by Aerobe culture

283

2083

1.41

6.43

1.6

1.7

—

(3025130) Human papilloma virus identified in Specimen

250

2.15

6.28

1.7

1.8

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

225

2.21

6.21

1.7

1.6

52.9

56.9

0.25

147

(3017143) Hepatitis C virus Ab [Presence] in Serum

256

1867

1.42

6.12

1.4

1.5

—

(36304419) Bacteria [Presence] in Urine

581

4806

1.29

6.01

2.8

3.0

—

(3030467) Casts [#/volume] in Urine by Automated count

594

4929

1.28

5.99

2.9

3.0

e6/l

0.3

0.4

1.12

445

3694

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

153

2.44

5.96

1.2

1.1

u/ml

79.7

38.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

510

4156

1.30

5.91

1.6

1.8

mg/l

1.0

1.1

0.82

383

3194

(3019309) Folate [Moles/volume] in Red Blood Cells

411

3253

1.33

5.89

1.7

nmol/l

1229.2

1199.1

0.26

296

2449

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

167

2.36

5.83

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

125

796

1.61

5.73

2.1

2.0

u/l

40.7

39.5

0.27

108

707

(3032080) INR in Blood by Coagulation assay

826

7174

1.25

5.58

5.8

8.4

inr

1.1

1.2

2.78

258

2046

(3021589) Normoblasts [#/volume] in Blood

942

8301

1.24

5.58

9.7

9.4

e9/l

0.0

0.16

797

6787

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

486

3964

1.29

5.56

1.7

pmol/l

124102996.7

32733262.4

1.06

390

3275

(3004616) Nuclear Ab [Presence] in Serum

236

2.10

5.55

1.3

1.2

—

(4010399)

197

1399

1.45

5.45

1.5

1.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

353

2768

1.33

5.37

2.1

2.5

umol/l

14.0

13.1

1.44

323

2555

(3002582) Erythrocytes [#/volume] in Urine

630

5326

1.26

5.35

2.9

3.1

e6/l

31.5

74.7

1.63

480

4058

(3003327) Ova and parasites identified in Stool by Light microscopy

583

1.68

5.32

1.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

114

724

1.61

5.30

1.5

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.90

5.19

4.1

2.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

525

4360

1.27

5.16

3.9

3.8

—

(3045414) Leukocytes [Presence] in Urine

134

890

1.54

5.15

1.9

2.0

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

325

2536

1.33

5.10

2.0

2.5

g/l

2.4

1.18

300

2347

(3023420) DNA double strand Ab [Units/volume] in Serum

211

2.11

5.07

2.1

1.4

iu/ml

28.8

29.8

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

104

2.62

5.06

1.3

1.5

umol/l

26.6

24.7

0.11

(3027135) IgG subclass 1 [Mass/volume] in Serum

185

2.18

5.04

1.5

g/l

6.2

7.2

1.08

130

(3028192) IgG subclass 2 [Mass/volume] in Serum

185

2.18

5.04

1.5

g/l

3.0

2.9

0.14

130

(3024139) IgG subclass 3 [Mass/volume] in Serum

185

2.18

5.04

1.5

g/l

0.3

0.4

0.60

131

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

379

3027

1.31

5.04

2.4

2.6

e6/l

0.7

1.3

3.34

210

1695

(3008898) HLA-B27 [Presence]

610

1.64

4.96

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

510

1.69

4.95

2.1

mg/l

9.5

11.8

2.10

470

(3018095) Leukocytes [#/volume] in Urine

734

6359

1.23

4.93

3.6

e6/l

84.0

92.4

0.11

522

4418

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

664

5692

1.24

4.91

2.1

u/l

157.9

181.4

0.62

617

5340

(3000570) Elastase.pancreatic [Mass/mass] in Stool

592

1.63

4.80

1.3

1.4

ug/g

287.0

287.6

0.01

335

(46235355) HIV 1 and 2 tests - Meaningful Use set

315

2469

1.32

4.79

1.5

1.6

—

(4062490)

190

2.13

4.74

1.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

203

1489

1.40

4.71

2.7

2.9

g/l

68.1

66.8

2.19

189

1345

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

299

2345

1.32

4.52

6.1

6.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

187

1365

1.41

4.48

1.2

iu/ml

135.3

148.9

0.22

524

(3029937) Albumin [Presence] in Urine by Test strip

570

4852

1.24

4.43

4.3

4.2

estimate

0.0

1.28

210

1649

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

140

971

1.47

4.41

1.1

1.0

—

(3017732) Neutrophils [#/volume] in Blood

178

1292

1.41

4.40

2.6

2.9

e9/l

3.9

4.0

0.32

133

1015

(4094501)

528

1.64

4.38

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

145

2.23

4.28

1.2

1.1

u/ml

2.0

2.6

—

(3009508) Creatinine [Moles/volume] in Urine

669

5816

1.22

4.21

3.0

3.1

mmol/l

7.1

7.0

0.18

558

4879

(3012516) Albumin [Mass/volume] in Urine

641

5555

1.22

4.15

3.0

3.2

mg/l

859.1

365.5

0.92

358

3298

(3023323) Follitropin [Units/volume] in Serum or Plasma

111

747

1.51

4.07

1.4

1.3

iu/l

32.1

35.4

0.48

102

644

(3004588) Protein electrophoresis panel - Serum or Plasma

172

1261

1.40

4.03

2.5

2.6

—

(3000850) Epithelial cells [#/volume] in Urine

445

3725

1.25

3.99

2.4

2.5

e6/l

4.3

6.6

5.20

393

3269

(3014051) Protein [Presence] in Urine by Test strip

465

1.64

3.92

2.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.69

3.82

1.3

1.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

781

6941

1.20

3.82

4.0

3.9

—

(3018418) pH of Serum or Plasma

653

5708

1.21

3.82

3.5

4.1

7.4

0.71

132

1077

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

300

2417

1.28

3.71

5.2

4.6

33.3

32.9

0.23

197

1605

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

3.01

3.69

1.3

1.4

42.5

28.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

151

1101

1.40

3.68

1.8

1.7

—

(3019225) pH of Specimen

245

1927

1.31

3.64

4.0

4.3

—

(3013512) EKG study

631

5523

1.20

3.61

3.8

3.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

113

785

1.46

3.59

2.2

nmol/l

14.1

12.5

1.17

101

693

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

776

6929

1.19

3.54

3.5

3.4

ng/l

308.2

47.8

0.45

483

4649

(3033658) Prothrombin time (PT) actual/Normal

547

4733

1.21

3.52

3.5

3.8

95.9

93.3

1.78

524

4604

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

110

764

1.46

3.50

1.3

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

1618

15391

1.21

3.49

17.2

17.1

13.5

13.7

3.95

1594

15053

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

957

8712

1.18

3.45

3.8

3.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

369

3073

1.24

3.44

5.3

4.7

ug/l

1.8

2.4

2.41

333

2751

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

146

2.07

3.42

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

268

2155

1.28

3.37

1.4

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

337

2786

1.25

3.36

2.6

2.8

e6/l

2.8

3.3

0.33

169

1461

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

291

2367

1.27

3.33

2.2

2.5

23.8

22.6

0.71

240

2017

(3006922) Hepatitis E virus Ab [Presence] in Serum

108

2.24

3.32

1.0

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

412

3487

1.22

3.30

3.3

3.5

ng/l

244.0

363.3

0.58

290

2647

(40760892) CBC W Ordered Manual Differential panel - Blood

475

4079

1.21

3.29

4.8

4.7

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

103

2.25

3.22

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

103

2.25

3.22

1.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

137

1009

1.38

3.18

2.2

2.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

300

2463

1.25

3.18

4.5

4.1

19.7

20.9

0.77

121

1132

(3020682) Albumin/Creatinine [Ratio] in Urine

658

5850

1.18

3.07

3.7

3.9

mg/mmol

5.2

8.1

1.19

369

3488

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

163

1242

1.34

3.06

1.9

1.8

—

(40758558) Short blood count panel - Blood

558

4898

1.19

3.02

6.2

6.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

648

1.45

2.96

1.7

1.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

511

1.51

2.89

1.6

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

685

0.59

2.88

1.8

2.0

ug/l

1.1

2.0

0.58

606

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

122

2.06

2.87

1.3

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

261

2147

1.25

2.73

2.4

2.6

umol/l

6.5

7.6

0.59

224

1865

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

438

1.52

2.69

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

240

1961

1.25

2.67

4.2

4.4

u/l

224.3

250.0

3.33

227

1851

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

119

2.03

2.66

1.3

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

544

4812

1.17

2.65

2.4

2.5

umol/l

2243.8

5077.1

1.15

462

4172

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

410

3546

1.19

2.60

2.6

3.1

mmol/l

2.4

2.5

0.82

360

3128

(40768441) Liver Pathology biopsy report

149

1.89

2.56

1.1

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

7.15

2.55

1.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

181

1439

1.28

2.53

1.8

2.9

ng/l

97.9

172.6

3.17

158

1307

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

301

1.61

2.51

1.2

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

263

1.65

2.48

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

463

1.48

2.48

1.6

e6/l

12459.0

11053.3

0.13

346

(3042936) Bacteria identified in Isolate by Culture

305

2578

1.21

2.47

1.9

2.1

—

(3028707) Methadone [Presence] in Urine by Screen method

166

1.82

2.45

1.4

2.0

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

675

1.39

2.42

2.4

2.6

g/l

10.2

0.01

571

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

713

1.38

2.35

1.6

1.5

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

229

1.67

2.33

2.0

1.9

pmol/l

216.4

204.9

0.27

215

(3036481) Cortisol [Moles/volume] in Serum or Plasma

219

1802

1.24

2.31

2.6

2.2

nmol/l

368.9

369.3

0.01

209

1652

(4035726)

222

1830

1.24

2.30

1.3

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

187

1514

1.26

2.28

2.6

2.5

ml/min/173m2

67.7

66.1

0.26

607

(3041096) Erythrocytes [Presence] in Urine by Automated

540

4828

1.16

2.27

3.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

1733

16771

1.17

2.25

15.6

15.0

40.3

39.5

4.30

1216

11976

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.28

2.24

1.4

1.2

—

(3019150) Specific gravity of Urine by Refractometry

450

3978

1.17

2.19

4.3

4.2

kg/l

1.0

0.49

580

(3026008) Bacteria identified in Urine by Culture

646

5864

1.15

2.19

3.2

3.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.13

2.18

1.7

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.13

2.18

1.7

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

337

1.53

2.17

1.3

u/l

11.7

13.3

0.31

267

(3002256) Pathology report gross observation

292

2490

1.20

2.17

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

218

1808

1.23

2.15

3.6

2.9

ug/l

0.6

0.7

2.16

137

1157

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

260

1.59

2.10

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.57

2.09

1.0

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

737

1.35

2.09

2.4

2.5

g/l

3.7

0.26

521

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

694

1.36

2.08

2.2

2.6

g/l

3.0

3.1

0.91

533

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

738

1.34

2.07

2.4

2.5

g/l

7.4

0.09

552

(3021788) Differential panel - Synovial fluid

325

1.52

2.07

1.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.33

2.05

1.3

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

262

1.58

2.04

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.41

2.02

1.0

1.4

90.8

90.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.08

2.01

1.3

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

738

1.33

1.94

2.4

2.5

—

(3022621) pH of Urine by Test strip

150

1210

1.26

1.92

2.9

3.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

151

1222

1.25

1.89

1.3

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

2.32

1.87

1.0

—

(44813793)

136

1.77

1.87

1.0

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

501

1.39

1.86

1.5

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

237

1.57

1.85

1.6

2.3

mg/l

16.9

26.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.54

1.84

1.0

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.51

1.83

1.2

1.9

—

(40761535) Cells panel - Urine sediment

182

1511

1.22

1.81

3.3

3.5

—

(3049717) Cytology report of Urine Cyto stain

590

1.35

1.80

2.3

2.4

—

(3045716) Anion gap in Serum or Plasma

2.01

1.80

2.0

2.2

mmol/l

7.8

10.3

1.68

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

573

1.36

1.80

2.1

2.5

g/l

38.9

37.8

1.09

493

(3025468) Yersinia sp identified in Specimen by Organism specific culture

255

1.54

1.79

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

255

1.54

1.79

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.77

1.79

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

192

1.62

1.78

1.3

e6/l

88477.7

64724.1

0.11

136

(3012095) Magnesium [Moles/volume] in Serum or Plasma

347

3059

1.16

1.76

2.8

3.3

mmol/l

0.8

0.09

321

2837

(3005988) Vibrio sp identified in Specimen by Organism specific culture

257

1.53

1.74

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.23

1.74

1.0

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

568

1.35

1.73

1.7

1.6

iu/ml

0.0

0.1

0.43

110

(3034860) Kappa light chains.free [Mass/volume] in Serum

560

1.35

1.72

3.6

3.9

mg/l

47.1

63.4

0.39

463

(3001893) Eosinophils/100 leukocytes in Pleural fluid

0.00

1.69

0.0

1.5

—

4.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

0.00

1.68

0.0

1.4

—

26.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

164

1.65

1.68

1.0

1.1

u/ml

0.0

0.2

—

(3025941) Bacteria identified in Stool by Culture

130

1052

1.25

1.66

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.81

1.65

1.0

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

471

1.37

1.62

1.2

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

159

1.64

1.59

1.2

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.70

1.58

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.70

1.58

1.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

561

1.33

1.56

3.6

3.9

mg/l

89.0

49.4

0.51

466

(3000492) Spirometry study

212

1816

1.19

1.55

1.5

—

(40761536) Microorganisms panel - Urine sediment

181

1530

1.20

1.53

4.1

4.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

511

1.34

1.53

2.2

2.6

g/l

0.0

0.00

472

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

143

0.42

1.51

1.5

umol/l

8.3

12.0

—

135

(3047181) Lactate [Moles/volume] in Blood

547

1.33

1.51

3.9

8.2

mmol/l

1.1

1.3

1.20

484

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.86

1.50

1.0

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

157

1312

1.21

1.50

1.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

231

0.52

1.50

1.0

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

558

1.32

1.47

2.1

2.6

g/l

0.0

0.51

512

(1002224) Polysomnography panel

744

1.28

1.47

1.1

—

(40768806) Pleura Pathology biopsy report

169

0.47

1.46

3.1

1.6

—

(3011412) CD3 cells [#/volume] in Blood

171

1.59

1.46

2.4

2.0

e9/l

0.9

1.1

0.56

107

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.37

1.45

1.4

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

551

1.32

1.45

1.8

1.7

—

(3003434) Protein [Mass/volume] in Pleural fluid

201

0.50

1.43

2.6

1.4

g/l

30.6

33.5

—

179

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

517

1.33

1.43

2.2

2.6

g/l

0.0

0.00

473

(3023520) Reticulocytes [#/volume] in Blood

167

1413

1.20

1.42

2.9

2.7

e9/l

72.0

72.2

0.01

128

1074

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

713

1.27

1.41

1.8

1.9

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.08

1.38

1.5

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.61

1.36

1.0

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

346

0.63

1.34

4.2

3.2

nmol/l

0.7

0.8

1.12

271

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

629

1.28

1.34

2.1

2.7

g/l

1.3

0.9

0.23

553

(40760888) Immunoglobulin light chains.free panel - Serum

410

1.35

1.33

3.6

4.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

136

1.62

1.32

1.6

1.9

13.5

14.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

543

1.30

3.8

3.9

ratio

4.1

1.6

—

(3026782) Osmolality of Urine

380

3445

1.13

1.29

2.7

mosm/kgh2o

490.6

527.4

3.00

321

2948

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.36

1.29

1.4

ng/l

97.9

80.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

448

0.69

1.28

5.9

4.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

252

1.44

1.26

1.0

1.1

u/ml

4.4

4.0

0.06

118

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.82

1.25

1.1

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

295

1.40

1.24

1.4

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

195

1.49

1.24

1.1

u/ml

1.1

2.4

1.02

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.05

1.22

1.2

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.64

1.21

4.6

5.0

—

(3006462) Nitrate [Presence] in Urine

1.80

1.21

3.1

3.7

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

132

1.60

1.20

1.9

1.8

—

(21494434) Karyotype in Bone marrow

164

1.53

1.20

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

225

1982

1.15

1.20

1.5

1.8

1.5

1.4

0.20

203

1731

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

157

1.53

1.17

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

223

1.44

1.16

1.0

1.1

u/ml

0.1

2.1

2.15

(4211845)

1.73

1.15

3.1

3.5

—

(4034850)

632

0.75

1.15

14.3

9.6

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

343

1.35

1.15

1.2

1.3

—

77.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

116

971

1.21

1.15

1.4

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

266

1.40

1.14

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

112

935

1.21

1.14

6.9

11.0

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

466

1.30

1.14

1.9

1.7

mu/l

308.4

309.8

0.01

419

(3004775) Volume in Urine collected for unspecified duration

155

0.51

1.13

1.6

2.3

888.8

633.8

—

105

(3017354) Segmented neutrophils/100 leukocytes in Blood

183

1.48

1.13

3.1

3.0

58.9

57.2

0.17

123

(3045788) Cell count panel - Pleural fluid

156

0.51

1.13

3.4

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.34

1.12

1.0

1.2

umol/24h

1.4

1.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

293

1.37

1.12

1.1

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

143

1.54

1.11

1.0

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

302

1.36

1.11

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

195

0.56

1.10

3.1

2.2

—

(4024509)

209

1.44

1.10

2.0

1.7

—

(40762814) Titanium [Mass/volume] in Blood

2.26

1.10

2.1

—

3.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

202

1780

1.15

1.09

2.4

2.3

u/l

58.2

38.4

0.34

169

1528

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

496

1.28

1.09

1.5

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

113

1.60

1.05

1.1

1.7

ug/l

3.0

5.9

0.55

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

652

1.24

1.04

1.6

1.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

213

1891

1.14

1.04

2.7

3.2

—

(3025159) Blasts/100 leukocytes in Blood

166

1449

1.16

1.03

3.6

4.3

0.1

0.5

0.75

363

(3003338) MCHC [Mass/volume]

1593

15564

1.09

1.02

18.9

18.1

g/l

332.4

331.5

3.35

1586

15466

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

171

1.47

1.02

1.8

1.5

35.3

38.1

0.11

109

(3024891) Influenza virus A+B Ag [Presence] in Specimen

473

0.74

1.02

1.1

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

109

0.46

1.00

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

274

1.36

0.99

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

149

1295

1.16

0.98

2.8

3.3

pmol/l

4.2

4.5

4.29

133

1147

(3016650) Hepatitis A virus Ab [Presence] in Serum

292

1.34

0.98

1.1

1.0

—

(21494815) CD4 cells/100 lymphocytes in Specimen

148

1.49

0.98

1.9

49.2

46.2

—

(3000034) Microalbumin [Mass/volume] in Urine

173

1.45

0.97

2.7

2.8

mg/l

11.0

25.2

0.94

118

(40762365) Oxygen content in Arterial blood by calculation

0.00

0.97

0.0

3.1

—

15.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1.86

0.96

2.0

2.7

—

53.6

—

(3011985) Renin [Units/volume] in Plasma

277

1.34

0.94

1.9

1.5

mu/l

60.9

41.5

0.48

253

(4146454)

217

1.39

0.93

2.8

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

143

0.56

0.93

3.8

6.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

481

1.25

0.93

1.4

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

383

1.29

0.92

3.3

3.6

59.1

57.3

0.51

383

(3036782) Glucose [Moles/volume] in Pleural fluid

146

0.55

0.92

1.6

1.3

mmol/l

5.2

6.4

—

133

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1.67

0.91

1.8

2.4

umol/l

69.4

52.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

102

1.57

0.90

1.2

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

288

1.33

0.90

1.3

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

167

1477

1.14

0.89

3.6

3.9

0.8

0.6

0.50

334

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

128

0.55

0.88

1.7

1.3

u/l

281.4

328.2

—

122

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.79

0.87

1.0

2.2

ug/l

0.7

1.5

—

(44790047)

217

0.64

0.87

1.4

—

(44790049)

217

0.64

0.87

1.4

—

(44790048)

217

0.64

0.87

1.4

—

(44806118)

217

0.64

0.87

1.4

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

2.00

0.87

1.7

1.5

109.0

107.7

—

(3052851) Hemolysis interference index of Serum or Plasma

568

1.22

0.86

2.8

3.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

167

1482

1.14

0.85

2.0

2.3

ug/l

7.7

6.8

0.19

140

1302

(3017704) Immunofixation for Urine

104

1.54

0.84

2.1

1.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.94

0.84

1.8

2.4

umol/l

15.6

20.0

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

808

0.82

0.83

2.3

2.6

1.2

0.10

803

(3009466) Valproate [Moles/volume] in Serum or Plasma

261

0.69

0.82

3.1

5.4

umol/l

345.5

374.9

0.31

226

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.88

0.81

1.0

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

391

1.26

0.81

1.3

1.6

—

(3019977) pH of Arterial blood

1.58

0.81

2.5

3.3

7.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

178

1593

1.13

0.81

3.6

3.8

mmol/l

1.2

0.36

161

1390

(3011288) Drugs identified in Urine by Screen method

250

1.33

0.80

1.6

2.4

—

(3027008) Opiates [Presence] in Urine

392

1.26

0.80

1.3

1.6

—

(3022689) Creatine [Moles/volume] in Urine

1.73

0.79

1.4

1.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.82

0.79

1.7

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

0.79

0.0

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

803

0.83

0.79

2.2

4.1

mmol/l

24.6

24.3

0.39

721

(3028300) Cannabinoids [Presence] in Urine

393

1.25

0.78

1.3

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

540

0.79

0.78

2.6

3.4

u/ml

0.3

0.4

0.48

306

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

199

0.65

0.78

1.2

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

199

1.36

0.78

1.0

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

182

1.38

0.78

4.6

3.7

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

0.00

0.77

0.0

1.1

—

2.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

183

1.37

0.76

1.0

1.1

u/ml

4.1

3.2

0.18

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

279

1.30

0.76

1.3

1.2

u/ml

1.8

3.9

0.78

(3024263) Appearance of Synovial fluid

1.52

0.75

1.1

1.7

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

173

0.63

0.75

4.1

2.6

—

(3002032) Base excess in Venous blood by calculation

137

1543

0.88

0.74

2.6

3.7

mmol/l

2.1

2.0

0.05

113

1271

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

306

2834

1.09

0.74

1.7

1.8

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

108

1.49

0.73

2.6

2.5

37.7

42.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

207

1882

1.11

0.73

2.6

1.8

0.38

188

1679

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

228

1.32

0.73

1.4

1.5

nmol/l

0.3

0.03

169

(3035637) Corticotropin [Mass/volume] in Plasma

228

1.32

0.73

1.5

1.6

—

(3012441) Differential panel - Pleural fluid

159

0.63

0.72

2.7

1.4

—

(40768795) Lymph node Pathology biopsy report

211

1.33

0.72

1.1

1.2

—

(3045424) Erythrocytes [Presence] in Urine

335

1.26

0.72

1.5

1.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

110

0.54

0.72

1.2

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

117

1.46

0.71

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.75

0.71

1.3

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

564

1.19

0.70

1.2

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

240

0.71

0.70

1.6

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

170

1535

1.12

0.69

3.7

4.2

0.3

0.1

0.88

427

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

442

0.79

0.69

1.5

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

1.67

0.68

1.1

1.9

—

(3016750) Collection duration of Urine

117

0.60

0.68

1.6

2.2

min

467.4

494.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

258

1.28

0.67

1.4

pmol/l

268.0

299.4

0.39

202

(3017181) Myelocytes/100 leukocytes in Blood

178

1615

1.11

0.67

3.8

4.2

1.6

0.9

0.77

465

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

153

1.38

0.67

1.2

u/ml

1.1

0.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

476

4509

1.07

0.67

2.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

558

1.19

0.67

1.2

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.63

0.67

6.0

3.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.53

0.66

4.6

3.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

162

1463

1.12

0.66

1.4

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

384

0.78

0.66

4.3

3.7

mg/l

13.7

24.8

3.07

240

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.53

0.66

1.0

1.7

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

1.79

0.66

1.0

1.2

—

67.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

268

1.27

0.65

1.7

1.6

—

(3016879) Cocaine [Presence] in Urine

358

1.23

0.65

1.3

1.7

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

190

0.68

0.65

1.2

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

190

0.68

0.65

1.2

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

331

1.24

0.65

1.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

259

2398

1.09

0.65

4.1

5.6

mmol/l

1.0

1.75

237

2216

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.59

0.65

1.3

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

251

1.28

0.64

1.1

u/ml

1.7

2.8

—

107

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.73

0.64

1.2

2.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

189

0.69

0.63

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

189

0.69

0.63

1.2

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

303

0.76

0.63

1.1

iu/ml

19.4

1968.9

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

279

1.26

0.62

1.2

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

101

0.59

0.62

1.5

1.6

—

(4015189)

1.63

0.62

3.5

2.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.63

0.62

3.9

2.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

554

1.18

0.61

1.2

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.67

0.61

1.0

1.2

—

66.7

—

(3000012) Reticulocyte production index

1.46

0.61

1.1

1.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.60

0.61

1.0

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

0.00

0.60

0.0

1.3

—

2220.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.60

0.0

8.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

1.2

—

218.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

0.00

0.58

0.0

1.1

—

3.7

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

0.00

0.58

0.0

1.6

—

10.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.58

0.0

2.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

246

1.26

0.58

1.0

1.1

u/ml

0.3

1.7

1.65

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

387

0.80

0.58

2.3

1.9

nmol/l

1.1

0.8

0.73

318

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.46

0.58

1.1

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

988

0.88

0.57

1.8

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.72

0.57

1.0

1.5

—

(3037121) Protein [Mass/volume] in Urine

625

1.16

0.56

2.0

3.3

g/l

0.2

2.30

242

(3022217) INR in Platelet poor plasma by Coagulation assay

239

2223

1.08

0.56

16.2

22.2

inr

1.1

1.3

3.19

300

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

159

1.32

0.55

1.2

—

(3025577) Chromium [Mass/volume] in Blood

116

1.38

0.54

2.6

2.1

ug/l

2.7

2.1

0.27

102

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.47

0.54

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.47

0.54

1.4

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.50

0.54

1.7

1.2

—

(3051651) Icteric interference index of Serum or Plasma

126

0.63

0.54

4.3

3.7

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

665

1.15

0.54

2.0

1.8

mg/l

2.9

3.9

0.44

480

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.54

0.53

1.0

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

370

0.81

0.52

1.1

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

370

0.81

0.52

1.1

1.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

0.62

0.52

1.8

1.2

u/l

8.8

10.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

100

0.60

0.51

1.3

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

203

0.74

0.51

1.1

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

248

0.76

0.51

1.3

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

370

1.19

0.51

3.2

2.2

g/l

125.9

129.3

0.47

270

(3020891) Body temperature

723

0.87

0.50

2.7

4.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

284

2675

1.07

0.49

1.6

2.1

29.1

29.4

0.49

277

2595

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

101

1.39

0.49

1.3

1.2

—

(3037756) Immunofixation for Serum or Plasma

390

1.18

0.49

2.3

1.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

443

0.83

0.49

2.2

2.4

ug/min

73.4

104.2

0.43

265

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

136

1.33

0.49

1.0

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

625

0.86

0.48

2.5

3.6

mmol/l

1.4

0.17

615

(40768800) Prostate Pathology biopsy report

190

1.27

0.48

1.4

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

290

1.21

0.47

1.1

u/ml

3.1

1.4

0.32

113

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

505

0.85

0.47

1.2

1.3

—

(3017569) Oxygen content in Arterial blood

1.41

0.47

1.3

2.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

111

1.35

0.46

1.4

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.43

0.46

3.4

3.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.43

0.46

3.4

3.0

—

(3000330) Specific gravity of Urine by Test strip

105

952

1.11

0.45

3.7

3.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

274

1.21

0.44

1.4

1.2

u/ml

5.4

5.5

0.01

104

(3048929) Epstein Barr virus Ab [Presence] in Serum

469

1.16

0.44

1.4

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

112

1.34

0.44

1.2

—

(3023419) Bacteria identified in Sputum by Culture

247

1.22

0.44

2.6

2.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

152

0.72

0.44

1.1

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

470

1.15

0.43

1.3

miu/ml

129.5

214.4

1.56

216

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

140

0.71

0.43

1.0

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.61

0.43

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

382

0.84

0.43

2.3

2.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

166

1543

1.08

0.43

3.0

3.6

ng/l

90.0

83.6

0.27

138

1323

(3052592) Norovirus Ag [Presence] in Stool

1.56

0.42

1.0

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

295

1.19

0.41

1.3

1.7

—

(3000991) Gas panel - Venous blood

132

1430

0.92

0.41

7.9

8.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

240

1.21

0.41

1.2

1.3

mmol/l

7.3

7.5

0.15

170

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.41

0.0

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

0.41

0.0

1.0

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.0

—

(3006653) Thiamine [Moles/volume] in Blood

105

1.34

0.41

1.6

1.3

nmol/l

133.4

136.3

0.08

105

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

222

1.22

0.41

1.2

u/l

40.3

54.4

1.55

159

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.40

0.0

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

0.00

0.40

0.0

1.1

—

28.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

444

0.85

0.40

1.4

1.6

—

(1761868) Lipid panel - Serum or Plasma

682

6624

1.04

0.40

2.8

2.9

—

(3024869) Neuronal Ab [Presence] in Serum

1.47

0.40

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.37

0.40

1.8

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.37

0.40

1.8

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.37

0.40

1.8

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.37

0.40

1.8

1.7

—

(3027944) Amphetamines [Presence] in Urine

390

1.16

0.39

1.4

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

171

0.76

0.39

2.7

2.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

409

1.15

0.39

2.9

mmol/l

24.7

25.0

0.25

359

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

259

0.81

0.39

1.1

1.6

—

(4306422)

279

1.19

0.38

1.1

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

694

1.11

0.38

2.3

3.6

u/ml

96.6

2291.5

0.88

590

(3014111) Lactate [Moles/volume] in Serum or Plasma

143

1537

0.93

0.38

6.9

6.8

mmol/l

1.2

1.3

0.83

135

1484

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.37

0.38

2.4

5.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.37

0.38

1.1

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

458

1.14

0.37

2.2

3.2

mg/l

1.2

1.6

3.19

429

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.33

0.37

1.4

1.3

—

(4281824)

279

0.82

0.37

1.0

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

119

1099

1.09

0.37

4.5

7.6

mmol/l

24.1

24.7

1.56

111

1030

(3043238) Trisomy 21 risk [Likelihood] in Fetus

158

0.76

0.37

1.2

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

115

0.69

0.37

1.4

1.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

116

1.30

0.37

2.8

2.2

e6/l

876.9

743.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

354

0.85

0.37

1.2

1.5

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

1.27

0.36

2.0

ug/l

66.7

61.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

180

1.22

0.36

1.0

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

0.66

0.35

2.0

2.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.65

0.35

2.0

2.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

199

1.21

0.35

2.9

3.7

—

(3019060) Gas panel - Arterial blood

108

1168

0.92

0.34

3.6

5.5

—

(4268621)

190

1.21

0.34

2.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

101

930

1.09

0.34

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

156

0.77

0.34

1.3

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

172

1.22

0.34

1.2

—

(3023368) Bacteria identified in Blood by Culture

483

4676

1.04

0.34

3.8

4.2

—

(3044941) Cell count panel - Synovial fluid

302

1.16

0.34

1.3

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

100

1.30

0.33

1.4

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

188

0.80

0.33

1.2

—

(3003694) ABO and Rh group [Type] in Blood

500

4849

1.04

0.32

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

294

1.16

0.32

1.4

u/ml

96.5

110.2

0.58

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.28

0.32

2.8

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

154

0.78

0.32

1.2

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.31

0.31

1.2

1.1

—

(3005033) Fetal Nuchal fold Thickness US

153

0.78

0.30

1.2

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

129

1.24

0.30

1.5

1.9

umol/l

10.4

5.4

0.78

(21494814) CD8 cells/100 lymphocytes in Specimen

1.31

0.30

1.7

1.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

515

1.11

0.29

1.8

1.7

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

163

0.80

0.29

1.3

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

607

5922

1.03

0.29

2.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.32

0.28

1.6

1.1

miu/ml

1136.6

1667.2

—

(3044927) Protein electrophoresis panel - Urine

186

1.18

0.28

1.2

—

(40768793) Breast Pathology biopsy report

614

1.09

0.27

1.3

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

1.25

0.27

1.3

1.4

42.8

45.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

198

2074

0.95

0.27

3.0

4.1

ug/l

4.0

24.2

2.35

153

1678

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

171

0.82

0.26

1.4

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.69

0.26

1.0

1.4

—

(3011648) Oxygen content in Venous blood

141

1.21

0.26

1.4

2.1

12.7

10.8

1.34

141

(3021901) Oxygen saturation in Capillary blood

291

1.14

0.26

3.2

2.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

511

1.10

0.25

1.6

1.9

iu/l

2.6

5.3

2.87

169

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

330

1.12

0.25

1.4

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.20

0.25

2.0

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.20

0.25

2.0

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.20

0.25

2.0

1.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

329

0.88

0.24

1.4

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

133

1.20

0.24

1.8

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

331

1.12

0.24

1.7

1.6

—

(3020491) Glucose [Moles/volume] in Blood

124

1.21

0.24

1.1

1.6

mmol/l

6.6

6.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

755

1.08

0.24

2.3

1.8

g/l

1.5

1.6

0.66

655

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

408

1.11

0.23

2.2

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

190

0.84

0.23

1.6

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

218

1.15

0.23

3.0

2.2

32.3

0.01

218

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

243

0.86

0.23

1.3

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

327

0.89

0.23

1.3

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

162

1.17

0.23

1.7

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

162

1.17

0.23

1.7

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

162

1.17

0.23

1.7

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.25

0.22

1.2

1.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

487

1.09

0.22

1.3

1.2

mg/l

427.2

518.1

2.14

464

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

231

0.86

0.22

1.2

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.21

0.0

1.2

—

3611.8

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

0.00

0.21

0.0

1.6

—

5.8

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

13.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.0

—

22.0

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.0

—

8.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.0

—

37.9

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

344

1.11

0.21

2.2

1.9

u/l

118.9

1960.5

—

143

(4198724)

1.16

0.21

1.8

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

145

0.83

0.21

1.2

1.6

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.21

0.0

2.8

—

(3025315) Body weight

0.00

0.21

0.0

5.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.21

0.0

5.5

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.0

—

(3042631) Mycobacterium sp identified in Specimen

249

1.13

0.20

2.0

2.7

—

(3016502) Oxygen saturation in Arterial blood

185

1780

1.04

0.20

6.7

8.1

97.1

95.8

5.54

178

1725

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.20

0.0

1.4

—

6.4

—

(3048879) Bone marrow aspiration report

1.25

0.20

2.2

2.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

175

1682

1.04

0.20

7.0

8.4

g/l

123.1

120.8

0.89

168

1628

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

108

1.20

0.20

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

108

1.20

0.20

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

384

1.10

0.20

1.1

1.3

—

(3014007) Fractional oxyhemoglobin in Arterial blood

107

1126

0.95

0.19

8.8

8.6

95.3

94.0

5.47

107

1119

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

231

1.13

0.19

3.3

nmol/l

2.4

29.4

0.60

226

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

186

0.86

0.19

1.4

1.5

—

(3028271) Lactate [Moles/volume] in Capillary blood

270

0.89

0.19

1.5

1.8

mmol/l

1.6

0.26

263

(3023410) Appearance of Cerebral spinal fluid

194

1.14

0.18

1.1

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

135

1294

1.05

0.18

3.4

3.8

u/ml

41.8

61.8

0.60

127

1253

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

206

0.87

0.18

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.19

0.18

1.1

1.0

—

(3010421) pH of Blood

476

0.92

0.17

3.2

3.7

7.4

0.09

385

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

917

0.95

0.17

10.0

9.3

mmol/l

24.3

24.5

0.36

865

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

138

1.16

0.17

1.4

1.6

u/l

7.3

5.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

426

1.08

0.17

1.2

1.3

e6/l

55.4

23.2

0.31

327

(3028626) Oxygen [Partial pressure] in Capillary blood

349

1.09

0.17

3.0

2.7

kpa

8.3

8.1

0.31

322

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.11

0.17

1.0

1.4

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

148

1.15

0.17

2.4

2.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.72

0.17

1.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

427

1.08

0.16

1.3

1.4

e6/l

121.0

1451.2

1.32

349

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.16

0.16

1.4

1.2

105.1

110.8

—

(3023183) Ammonium ion [Moles/volume] in Plasma

391

0.92

0.16

3.2

3.1

umol/l

30.5

35.4

0.81

335

(3051593) INR in Capillary blood by Coagulation assay

1.11

0.16

1.0

12.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.11

0.16

1.9

1.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

266

0.90

0.15

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

266

0.90

0.15

1.0

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

380

1.08

0.15

1.4

1.7

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

119

0.84

0.15

1.5

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.14

0.15

1.0

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

226

2200

1.03

0.15

6.2

6.7

mmol/l

104.5

104.2

0.65

220

2156

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

108

1036

1.04

0.15

6.6

6.7

mmol/l

24.9

25.1

0.20

108

1027

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

1.18

0.14

2.0

1.7

nmol/l

4.2

5.3

—

(40767503) Oxygen content in Capillary blood by calculation

353

1.08

0.14

3.1

2.5

15.6

16.3

0.46

180

(3036489) Thrombin time

685

1.05

0.14

1.7

1.9

20.5

21.3

1.38

599

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

180

1.11

0.13

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

238

1.09

0.13

1.0

1.1

—

(3005570) Glucose [Moles/volume] in Urine

190

0.89

0.13

2.4

2.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

109

1051

1.04

0.13

3.5

3.4

kpa

5.1

5.2

0.39

100

978

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

277

1.08

0.12

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

127

0.87

0.12

3.6

2.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

104

1.15

0.12

1.1

1.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

568

0.95

0.11

3.4

2.7

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

108

1116

0.97

0.11

8.7

8.6

0.7

0.14

108

1110

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

279

1.08

0.11

1.5

1.3

nmol/l

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

309

1.07

0.10

1.4

1.2

u/ml

302.2

267.7

0.36

182

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

554

1.05

0.10

1.3

1.2

—

(3047189) Immunofixation for 24 hour Urine

1.15

0.10

2.6

1.7

—

(3009343) pH of Capillary blood

107

1038

1.03

0.10

3.6

3.4

7.4

0.23

137

(1616796) Gas panel - Central venous blood

371

0.94

0.09

4.5

3.6

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

109

1122

0.97

0.09

8.6

8.5

1.3

0.05

109

1115

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

381

0.94

0.09

1.6

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

103

1000

1.03

0.09

3.6

3.4

mmol/l

1.6

1.8

0.25

764

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

350

1.06

0.09

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

227

0.92

0.09

1.3

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

1.13

0.09

1.6

2.4

—

38.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

278

0.93

0.09

1.3

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.11

0.09

1.7

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.09

0.09

1.7

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.03

0.08

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

113

0.88

0.08

1.1

1.5

—

(3034426) Prothrombin time (PT)

0.83

0.08

1.2

1.3

—

(3033799) Differential panel - Peritoneal fluid

0.77

0.08

1.2

1.9

—

(40765096) Chromosome analysis panel by Banding

1.09

0.08

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

1.09

0.08

1.6

1.7

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

199

2024

0.98

0.08

6.5

7.6

kpa

5.1

0.39

192

1944

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.03

0.07

1.0

1.1

iu/ml

118.5

209.5

—

(3028433) Virus identified in Specimen by Culture

1.03

0.07

1.0

1.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

199

2023

0.98

0.07

6.4

7.6

kpa

13.1

12.6

0.66

192

1941

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

154

1570

0.98

0.07

1.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.07

0.07

1.3

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

108

1.11

0.07

1.0

1.1

u/l

1.1

—

(3014271) Vancomycin [Susceptibility]

0.83

0.07

3.6

2.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.82

0.07

1.7

1.4

—

(3015183) Erythrocyte sedimentation rate

1.06

0.07

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

0.86

0.06

1.1

—

(4027681)

104

0.86

0.06

1.0

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

101

1032

0.98

0.06

1.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1011

0.98

0.06

1.4

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

129

1.09

0.05

1.1

—

(3027315) Oxygen [Partial pressure] in Blood

395

0.96

0.05

3.5

3.9

kpa

8.7

8.6

0.25

387

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

197

1996

0.99

0.05

1.6

1.8

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

151

0.93

0.05

1.6

2.2

u/field

1.0

2.2

—

(3013290) Carbon dioxide [Partial pressure] in Blood

394

0.96

0.05

3.5

3.9

kpa

5.1

0.03

386

(3022313) Gas panel - Capillary blood

754

1.02

0.04

3.4

3.5

—

(3012501) Base excess in Blood by calculation

393

0.97

0.04

3.5

3.9

mmol/l

2.4

2.7

0.36

274

(3025018) Bordetella pertussis Ab [Titer] in Serum

109

0.92

0.04

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

517

1.03

0.04

2.1

2.3

202.2

190.8

0.36

495

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

197

1989

0.99

0.03

1.6

1.7

—

(21494755) Public health laboratory ask at order entry panel

153

1513

1.01

0.03

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

139

0.93

0.03

1.1

—

(3003396) Base excess in Arterial blood by calculation

203

2013

1.01

0.03

6.4

7.6

mmol/l

0.7

1.3

2.04

158

1611

(3003181) Sodium [Moles/volume] in Urine

341

1.03

0.02

1.5

1.4

mmol/l

60.7

59.6

0.06

275

(3020779) Urea [Moles/volume] in Serum or Plasma

152

1530

0.99

0.01

4.5

7.8

mmol/l

7.0

9.3

5.65

144

1462

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

106

1051

1.01

0.01

1.6

1.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

193

1.04

0.01

3.0

2.2

—

(3045142) Bone marrow Pathology biopsy report

233

1.03

0.01

1.1

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

104

1.06

0.01

1.8

u/field

1.3

2.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

196

0.97

0.00

1.2

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

189

1.01

0.00

1.6

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

209

1.00

0.00

3.3

3.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

321

1.00

0.00

1.5

1.3

nmol/l

0.6

0.06

307

(3004451) EKG impression Narrative

1.04

0.00

1.9

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

146

1.03

0.00

1.4

1.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

214

0.98

0.00

1.3

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

208

1.01

0.00

1.6

1.7

—

(3024928) Oxygen saturation in Venous blood

368

1.01

0.00

1.8

3.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

127

1.02

0.00

1.5

1.6

—

(3020876) Protein [Mass/time] in 24 hour Urine

157

1.02

0.00

2.1

2.0

—

1.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

13.2

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.0

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

0.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.94

0.00

1.4

2.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

300

1.00

0.00

1.4

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.0

1.4

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.0

4.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

100

1.00

0.00

1.1

1.4

mmol/l

5.5

6.0

—

(3013762) Body weight Measured

0.00

0.0

1.4

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

4.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.90

0.00

1.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

2.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.99

0.00

1.3

2.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.98

0.00

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.94

0.00

1.2

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3007733) Chloride [Moles/volume] in Urine

0.00

0.0

1.2

—

78.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

0.95

0.00

1.0

1.3

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.8

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.96

0.00

2.4

2.0

ug/l

25.2

114.4

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

1.7

—

16.3

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.1

—

376.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

0.91

0.00

1.3

1.1

99.0

94.4

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.5

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.8

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: K11_ORAL_LICHEN_PLANUS_INCLAVO – Oral lichen ruber planus, including avohilmo

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Oral lichen ruber planus, including avohilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Oral lichen ruber planus, including avohilmo (K11_ORAL_LICHEN_PLANUS_INCLAVO)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints